CYLD Limits Lys63- and Met1-Linked Ubiquitin at Receptor Complexes to Regulate Innate Immune Signaling
Open Access
- 1 March 2016
- journal article
- research article
- Published by Elsevier in Cell Reports
- Vol. 14 (12) , 2846-2858
Abstract
No abstract availableKeywords
Funding Information
- EMBO
- Medical Research Council (U105192732)
- Lundbeck Foundation
- European Research Council (309756)
- Deutsche Krebshilfe (111738)
- Lister Institute of Preventive Medicine
- Deutsche Forschungsgemeinschaft (FOR2036)
- Else Kröner-Fresenius-Stiftung (2014_A185)
- Wellcome Trust (102894/Z/13/Z)
- Ludwig Institute for Cancer Research
This publication has 51 references indexed in Scilit:
- Polyubiquitin-sensor proteins reveal localization and linkage-type dependence of cellular ubiquitin signalingNature Methods, 2012
- A ubiquitin ligase complex assembles linear polyubiquitin chainsThe EMBO Journal, 2006
- Critical role for Daxx in regulating Mdm2Nature Cell Biology, 2006
- The Crohn's Disease Protein, NOD2, Requires RIP2 in Order to Induce Ubiquitinylation of a Novel Site on NEMOCurrent Biology, 2004
- NF-κB Is Essential for Induction of CYLD, the Negative Regulator of NF-κBJournal of Biological Chemistry, 2004
- De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signallingNature, 2004
- Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κBNature, 2003
- CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family membersNature, 2003
- The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitinationNature, 2003
- Failure to Regulate TNF-Induced NF-κB and Cell Death Responses in A20-Deficient MiceScience, 2000